1. Stolk P, Willemen MJC, Leufkens HGM. Rare essential drugs for rare diseases as essential medicines. Bulletin of the World Health Organization, 206, 86(9): 746-751
2. Federal Law No. 323-FZ «On fundamental healthcare principles in the Russian Federation» of November 11, 2011 (as amended on 07.03.2018).
3. Donnart A, Viollet V, Roinet-Tournay M. Rare diseases, definitions and epidemiology. Soins Pediatrie, puericulture, 2013, 274: 14–16.
4. Implementation report Health and Consumers on the Commission Communication on Rare Diseases: Europe’s challenges and Council Recommendation of 8 June 2009 on an action in the field of rare diseases no. Accessible through: https://ec.europa.eu/health/sites/health/files/rare_diseases/docs/2014_rarediseases_implementationreport_en.pdf
5. Gildeeva GN, Kartavtsova TV. Legal regulation of the orphan drug life cycle. Problems of social hygiene, public health and history of medicine, 2014, 3: 38-42.